INOTEK PHARMACEUTICALS CORP - NOTE 5.750% 8/0 Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2016 to Q3 2021

Type / Class
Debt / NOTE 5.750% 8/0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INOTEK PHARMACEUTICALS CORP - NOTE 5.750% 8/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2021 Q3 $0 $0 -$5,785,000 0
2021 Q2 $4,000,000 $5,785,000 144.63% 1
2021 Q1 $4,000,000 $5,700,000 142.5% 1
2020 Q4 $4,000,000 $7,872,000 196.8% 1
2020 Q3 $4,000,000 $4,633,000 115.83% 1
2020 Q2 $4,000,000 $4,432,000 -$9,178,000 110.8% 1
2020 Q1 $13,500,000 $13,396,000 -$48,349,000 97.31% 3
2019 Q4 $57,150,000 $63,043,000 109.71% 8
2019 Q3 $57,150,000 $56,776,000 +$6,253,101 99.2% 8
2019 Q2 $50,850,000 $51,317,000 -$6,997,945 100.14% 8
2019 Q1 $57,577,000 $58,137,000 +$3,391,701 100.88% 8
2018 Q4 $54,303,000 $51,725,000 -$2,862,874 95.0% 8
2018 Q3 $48,933,000 $54,365,000 +$117,582 111.13% 8
2018 Q2 $49,273,000 $50,102,000 -$871,328 101.61% 10
2018 Q1 $50,559,000 $48,564,000 +$8,951,734 96.05% 12
2017 Q4 $41,600,000 $33,122,000 -$2,367,477 80.0% 9
2017 Q3 $44,550,000 $34,816,000 -$1,061,250 78.4% 9
2017 Q2 $50,000,000 $30,383,000 +$4,882 60.0% 11
2017 Q1 $50,000,000 $30,709,000 -$5,146,007 59.83% 10
2016 Q4 $52,000,000 $53,959,000 +$113,969 104.0% 11
2016 Q3 $52,000,000 $70,026,000 +$70,026,000 134.58% 10